Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The report details the trend, potential and market size of Ovarian Cancer Treatment Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ovarian Cancer Treatment Drugsmarket, defines the market attractiveness level of Ovarian Cancer Treatment Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ovarian Cancer Treatment Drugs industry, describes the types of Ovarian Cancer Treatment Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ovarian Cancer Treatment Drugs market and the development prospects and opportunities of Ovarian Cancer Treatment Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ovarian Cancer Treatment Drugs market in Chapter 13.
By Player:
Polaris Pharma
Tesaro
Clovis Oncology
Kazia Therapeutics
AstraZeneca
Roche
By Type:
Platinum Anticancer Drugs
Fluoropyrimidines
Anthracycline Antibiotics
Therapertic Antibody
Small Molecules Drug
Aromatase Inhibitors (Targeted Therapy Drug)
Anti-estrogens
Aromatase Inhibitors (Endocrine Therapy Drug)
By End-User:
Hospital
Clinic
Drugstore
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ovarian Cancer Treatment Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ovarian Cancer Treatment Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ovarian Cancer Treatment Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ovarian Cancer Treatment Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ovarian Cancer Treatment Drugs Market Analysis and Outlook to 2022
-
7.1 Global Ovarian Cancer Treatment Drugs Consumption (2017-2022)
-
7.2 United States Ovarian Cancer Treatment Drugs Consumption (2017-2022)
-
7.3 Europe Ovarian Cancer Treatment Drugs Consumption (2017-2022)
-
7.4 China Ovarian Cancer Treatment Drugs Consumption (2017-2022)
-
7.5 Japan Ovarian Cancer Treatment Drugs Consumption (2017-2022)
-
7.6 India Ovarian Cancer Treatment Drugs Consumption (2017-2022)
-
7.7 South Korea Ovarian Cancer Treatment Drugs Consumption (2017-2022)
8 Region and Country-wise Ovarian Cancer Treatment Drugs Market Analysis and Outlook to 2028
-
8.1 Global Ovarian Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.2 United States Ovarian Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Ovarian Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.4 China Ovarian Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Ovarian Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.6 India Ovarian Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Ovarian Cancer Treatment Drugs Consumption Forecast (2022-2028)
9 Global Ovarian Cancer Treatment Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Ovarian Cancer Treatment Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Platinum Anticancer Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Fluoropyrimidines Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anthracycline Antibiotics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Therapertic Antibody Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Small Molecules Drug Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Aromatase Inhibitors (Targeted Therapy Drug) Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Anti-estrogens Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Aromatase Inhibitors (Endocrine Therapy Drug) Consumption and Growth Rate (2017-2022)
-
9.2 Global Ovarian Cancer Treatment Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drugstore Consumption and Growth Rate (2017-2022)
10 Global Ovarian Cancer Treatment Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Ovarian Cancer Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Platinum Anticancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Fluoropyrimidines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anthracycline Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Therapertic Antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Small Molecules Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Aromatase Inhibitors (Targeted Therapy Drug) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Anti-estrogens Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Aromatase Inhibitors (Endocrine Therapy Drug) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ovarian Cancer Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
11 Global Ovarian Cancer Treatment Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ovarian Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ovarian Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ovarian Cancer Treatment Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ovarian Cancer Treatment Drugs Market Competitive Analysis
-
14.1 Polaris Pharma
-
14.1.1 Polaris Pharma Company Details
-
14.1.2 Polaris Pharma Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Polaris Pharma Ovarian Cancer Treatment Drugs Product and Service
-
14.2 Tesaro
-
14.2.1 Tesaro Company Details
-
14.2.2 Tesaro Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Tesaro Ovarian Cancer Treatment Drugs Product and Service
-
14.3 Clovis Oncology
-
14.3.1 Clovis Oncology Company Details
-
14.3.2 Clovis Oncology Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Clovis Oncology Ovarian Cancer Treatment Drugs Product and Service
-
14.4 Kazia Therapeutics
-
14.4.1 Kazia Therapeutics Company Details
-
14.4.2 Kazia Therapeutics Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Kazia Therapeutics Ovarian Cancer Treatment Drugs Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Ovarian Cancer Treatment Drugs Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Ovarian Cancer Treatment Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ovarian Cancer Treatment Drugs
-
Figure Ovarian Cancer Treatment Drugs Picture
-
Table Global Ovarian Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ovarian Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ovarian Cancer Treatment Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ovarian Cancer Treatment Drugs Consumption by Country (2017-2022)
-
Figure United States Ovarian Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Ovarian Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Ovarian Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Ovarian Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Ovarian Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ovarian Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Ovarian Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ovarian Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ovarian Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ovarian Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ovarian Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ovarian Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Platinum Anticancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Fluoropyrimidines Consumption and Growth Rate (2017-2022)
-
Figure Global Anthracycline Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Therapertic Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Small Molecules Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Aromatase Inhibitors (Targeted Therapy Drug) Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-estrogens Consumption and Growth Rate (2017-2022)
-
Figure Global Aromatase Inhibitors (Endocrine Therapy Drug) Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Drugstore Consumption and Growth Rate (2017-2022)
-
Figure Global Platinum Anticancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fluoropyrimidines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anthracycline Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapertic Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small Molecules Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aromatase Inhibitors (Targeted Therapy Drug) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-estrogens Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aromatase Inhibitors (Endocrine Therapy Drug) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ovarian Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ovarian Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Polaris Pharma (Foundation Year, Company Profile and etc.)
-
Table Polaris Pharma Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Polaris Pharma Ovarian Cancer Treatment Drugs Product and Service
-
Table Tesaro (Foundation Year, Company Profile and etc.)
-
Table Tesaro Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tesaro Ovarian Cancer Treatment Drugs Product and Service
-
Table Clovis Oncology (Foundation Year, Company Profile and etc.)
-
Table Clovis Oncology Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clovis Oncology Ovarian Cancer Treatment Drugs Product and Service
-
Table Kazia Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Kazia Therapeutics Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kazia Therapeutics Ovarian Cancer Treatment Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Ovarian Cancer Treatment Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Ovarian Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Ovarian Cancer Treatment Drugs Product and Service
-
